H
Loading...
Loading...
Fibrin matrix therapy uses the patient’s clotting proteins as a scaffold and sealant. It is autologous biology, prepared point-of-care, not an allogeneic stem-cell product.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18.
Fibrin matrix therapy supports wound healing with natural clotting factors. Platelet fibrin matrix from autologous sources.
Fibrin matrix uses clotting biology as a scaffold. It is adjacent to PRP, not a shortcut around MAC CTP rules if you were actually trying to bill a skin substitute. Read the IFU before the first case.
Fibrin is how wounds start healing. Concentrating it is a biologic idea with a specific kit IFU.
Some uses are intraoperative; some are clinic wounds. Do not assume one kit covers both.
Commercial fibrin sealants may be devices with different files. Know which you opened.
Autologous kits use the patient’s blood.
Related family, different fraction emphasis. Follow the IFU.
Both appear; protocols differ.
Indication-specific; do not copy CTP logic.
Contact us today to learn how Hawk Medical can support your practice.
We're not just a distributor - we're healthcare providers who understand your challenges
We own and operate medical clinics, so we understand your real-world challenges
All products meet strict regulatory requirements including HCT/P 361 compliance
Personal account management and ongoing training for your entire team
10+ years of experience helping practices implement successful programs
Learn more about related treatments, solutions, and resources
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.